Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of Pefcalcitol in Plaque Psoriasis
NCT01908595Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Aug 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pefcalcitol in plaque psoriasis, sponsored by Maruho Co., Ltd. Primary endpoint: Investigator Global Assessment. Started Aug 2013; status: completed.
02
Drugs
pefcalcitol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01908595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908595.